Lactobacillus fermentum, a pathogen in documented cholecystitis
- PMID: 23792476
- PMCID: PMC3710909
- DOI: 10.1016/j.ijscr.2013.04.034
Lactobacillus fermentum, a pathogen in documented cholecystitis
Abstract
Introduction: Lactobacillus species are probiotics proven to exhibit various preventative as well as therapeutic properties. While lactobacillus species have been implicated in the formation of dental caries, endocarditis and bacteremia, their role as pathogens in cholecystitis has not been reported. We present a rare case of Lactobacillus fermentum working as a pathogen in cholecystitis.
Presentation of case: An 81-year old male was admitted with right upper quadrant abdominal pain. His signs, symptoms, laboratory values and imaging were consistent with a diagnosis of cholecystitis with ascending cholangitis. In view of his co-morbidity and severe sepsis, the patient was treated non-operatively with antibiotics and cholecystostomy. L. fermentum, which was vancomycin resistant, was identified from the cholecystostomy aspirate and from anaerobic blood culture. The patient went into septic shock, developed multi-organ dysfunction syndrome and eventually died.
Discussion: Commensal bacteria such as L. fermentum are known to modulate immunity, reduce the pathogenicity of gastrointestinal organisms and play a therapeutic role in various disease processes. We isolated L. fermentum as a pathogen in a documented case of cholecystitis with ascending cholangitis.
Conclusion: While the routine use lactobacillus species as a probiotic is supported in the literature, understanding its potential role as a pathogen may allow more judicious use of these bacteria and encourage research to elucidate the pathogenicity of lactobacillus species.
Keywords: Cholangitis; Cholecystitis; Lactobacillus; Multi-organ dysfunction syndrome; Pathogenicity; Probiotic.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
An Unusual Case of Acute Cholecystitis Caused by Lactobacillus paracasei.Cureus. 2023 Jun 12;15(6):e40334. doi: 10.7759/cureus.40334. eCollection 2023 Jun. Cureus. 2023. PMID: 37456472 Free PMC article.
-
Distinguishing Between Gangrenous Cholecystitis and Ascending Cholangitis: A Case Study.Cureus. 2022 Aug 23;14(8):e28322. doi: 10.7759/cureus.28322. eCollection 2022 Aug. Cureus. 2022. PMID: 36034059 Free PMC article.
-
Anti-adhesion Property of the Potential Probiotic Strain Lactobacillus fermentum 8711 Against Methicillin-Resistant Staphylococcus aureus (MRSA).Front Microbiol. 2018 Mar 8;9:411. doi: 10.3389/fmicb.2018.00411. eCollection 2018. Front Microbiol. 2018. PMID: 29568290 Free PMC article.
-
Probiotic potential comparison of Lactobacillus strains isolated from Iranian traditional food products and human feces with standard probiotic strains.J Sci Food Agric. 2019 Dec;99(15):6680-6688. doi: 10.1002/jsfa.9945. Epub 2019 Sep 17. J Sci Food Agric. 2019. PMID: 31328278
-
Acute Cholecystitis Complicated with Gallbladder Perforation and Peritonitis Caused by Vancomycin-resistant Lactobacillus paracasei.Cureus. 2020 Mar 30;12(3):e7476. doi: 10.7759/cureus.7476. Cureus. 2020. PMID: 32351854 Free PMC article.
Cited by
-
Evolution of homologous recombination rates across bacteria.Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2316302121. doi: 10.1073/pnas.2316302121. Epub 2024 Apr 24. Proc Natl Acad Sci U S A. 2024. PMID: 38657048 Free PMC article.
-
An Unusual Case of Acute Cholecystitis Caused by Lactobacillus paracasei.Cureus. 2023 Jun 12;15(6):e40334. doi: 10.7759/cureus.40334. eCollection 2023 Jun. Cureus. 2023. PMID: 37456472 Free PMC article.
-
Lactobacillus Bacteremia and Probiotics: A Review.Microorganisms. 2023 Mar 30;11(4):896. doi: 10.3390/microorganisms11040896. Microorganisms. 2023. PMID: 37110319 Free PMC article. Review.
-
Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial.Cells. 2022 Oct 29;11(21):3419. doi: 10.3390/cells11213419. Cells. 2022. PMID: 36359816 Free PMC article. Clinical Trial.
-
Probiotics: Should All Patients Take Them?Microorganisms. 2021 Dec 18;9(12):2620. doi: 10.3390/microorganisms9122620. Microorganisms. 2021. PMID: 34946221 Free PMC article. Review.
References
-
- Plant L., Lam C., Conway P.L., O’Riordan K. Gastrointestinal microbial community shifts observed following oral administration of a Lactobacillus fermentum strain to mice. FEMS Microbiology Ecology. 2003;43(March (2)):133–140. - PubMed
-
- Chin J., Turner B., Barchia I., Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunology and Cell Biology. 2000;78:55–66. - PubMed
-
- Varma P., Dinesh K.R., Menon K.K., Biswas R. Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens. Journal of Food Science. 2010;75(November–December (9)):M546–M551. - PubMed
-
- Gan B.S., Kim J., Reid G., Cadieux P., Howard J.C. Lactobacillus fermentum RC-14 inhibits staphylococcus aureus infection of surgical implants in rats. Journal of Infectious Diseases. 2002;185(May (9)):1369–1372. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials